Ribo Life Science Marks Major Milestone with Successful IPO on Hong Kong Stock Exchange Ribo Life Science has successfully listed on the Hong Kong Stock Exchange, raising over HKD 1.8 billion, highlighting investor confidence in siRNA therapeutics.

Ribo Life Science Marks Major Milestone with Successful IPO on Hong Kong Stock Exchange #China #Hong_Kong #Hong_Kong_IPO #Ribo_Life_Science #siRNA_therapeutics